Health

Prof. Zembala is president-elect of the European Association for Cardio-Thoracic Surgery

Former minister of health, director of the Silesian Center for Heart Diseases in Zabrze Prof. Marian Zembala became president-elect of the European Association for Cardio-Thoracic Surgery (EACTS) during the annual meeting of the organization that took place on 1 - 5 October in Barcelona.

The Silesian Center for Heart Diseases announced the nomination last week on Tuesday.

Born in 1950 in Krzepice, Prof. Marian Zembala is a cardiac surgeon and transplantologist, former student of Prof. Zbigniew Religa, whom he assisted during the first successful heart transplant. In 1997 he was the first in Poland to conduct transplantation of a single lung, and in 2001, also as Poland\'s first, he successfully transplanted both lungs and heart in a patient.

Since 1993 he heads the Silesian Center for Heart Diseases in Zabrze - one of the leading institutions of this profile in the country. He is a member of the Polish Academy of Sciences and former national consultant in the field of cardiac surgery.

From June to November 2015 he was the health minister in the government of Prime Minister Ewa Kopacz (PO), currently he is a Civic Platform deputy.

PAP - Science and Scholarship in Poland

lun/ mrt/

tr. RL

The PAP Foundation allows free reprinting of articles from the Nauka w Polsce portal provided that we are notified once a month by e-mail about the fact of using the portal and that the source of the article is indicated. On the websites and Internet portals, please provide the following address: Source: www.scienceinpoland.pl, while in journals – the annotation: Source: Nauka w Polsce - www.scienceinpoland.pl. In case of social networking websites, please provide only the title and the lead of our agency dispatch with the link directing to the article text on our web page, as it is on our Facebook profile.

More on this topic

  • Adobe Stock

    Scientists grow lab-made blood vessels offering alternative to animal testing

  • Adobe Stock

    Biosynthetic drug could ‘transform treatment of infections, cancer and neurological disease’

Before adding a comment, please read the Terms and Conditions of the Science in Poland forum.